VENLO, The Netherlands, July 30 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) announced today the successful completion of its acquisition of Digene...
NEW YORK, July 27 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the...
Anticipates Prompt Completion of Acquisition VENLO, Netherlands, July 26 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has...
GAITHERSBURG, Md., July 25 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) will continue to supply Quest Diagnostics' (NYSE:DGX) network of labs in the U.S. with instrumentation and...
GAITHERSBURG, Md., July 24 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) announced that the U.S. District Court for the Western District of Wisconsin issued a pre-trial claim construction...
NEW YORK, July 23 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices: -- S&P 500 constituent American Standard Companies...
GAITHERSBURG, Md., July 23 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) today announced that a California state court has dismissed a complaint filed against the company by Gen-Probe...
VENLO, Netherlands and GAITHERSBURG, Md, July 17 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and Digene Corp. (NASDAQ:DIGE) announced that the antitrust...
GAITHERSBURG, Md., July 16 /PRNewswire-FirstCall/ -- Digene Corp. (NASDAQ:DIGE) today announced that on July 13, the panel hearing the arbitration proceeding between Digene and Roche granted...
Focus to Include Education on Both HPV Testing and Vaccination GAITHERSBURG, Md., June 21 /PRNewswire/ -- The Global Summit of Women concluded its 13th annual meeting in Berlin by announcing the...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관